Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019. - PowerPoint PPT Presentation

Loading...

PPT – Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019. PowerPoint presentation | free to download - id: 75bf41-ODcwO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019.

Description:

Big Market Research provides a new Report Package "Global Cancer Biomarkers Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Info At: Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Get Enquire About This Report At: – PowerPoint PPT presentation

Number of Views:14

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019.


1
Global Cancer Biomarkers Market 2015-2019
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2015 -
2019
No Of Pages 89
Published Date Jan 2015
2
Report Description
About Cancer Biomarkers Biomarkers are molecules
present in the blood, other body fluids such as
serum, urine, or in tissue that are indicators of
a disease or abnormal conditions. Biomarkers are
mostly used as diagnostic tools. Biomarkers help
in identifying potential drug failures in initial
stages, leading to savings in time and costs.
Biomarkers are becoming an essential part of the
drug discovery process. Cancer Biomarkers are
proteins or metabolites indicative of tumor state
and progression characteristics. They are
non-invasive, enable high speed cancer diagnosis
and also enhance early cancer detection and
screening. The best example of a cancer
biomarker is that of prostate specific antigen.
PSA is measured in the blood to screen for and
monitor treatment for prostate cancer. PSA, as a
biomarker helps the doctors to monitor the
progress of the cancer. It also helps to evaluate
the response of the cancer to the treatment
therapy. Global Cancer Biomarkers market to grow
at a CAGR of 18.26 percent over the period
2014-2019. Get Complete Report At
http//www.bigmarketresearch.com/global-cancer-bio
markers-2015-2019-market Covered in this
Report Global Cancer Biomarkers Market 2015-2019,
has been prepared based on an in-depth market
analysis with inputs from industry experts. The
report covers the Americas, and the EMEA and APAC
regions it also covers the Global Cancer
Biomarkers market landscape and its growth
prospects in the coming years.
3
Report Description
The report also includes a discussion of the key
vendors operating in this market. Key Regions
Americas APAC EMEA Key Vendors
Abbott Laboratories Affymetrix Illumina
Qiagen Quest Diagnostics Roche
Diagnostics Enquire At http//www.bigmarketresea
rch.com/report-enquiry/169860 Key Regions
Americas APAC EMEA Key Vendors Bio-Rad
Laboratories Fluidigm RainDance Technologies

4
Report Description
Other Prominent Vendors Agendia Agilent
Technologies Alere Ambry Genetics Amgen
Astellas Pharma US Astex Pharmaceuticals
Atossa Genetics Beckman Coulter Becton,
Dickinson and Company Biocurex bioMérieux
Celldex Therapeutics Clarient diaDexus
DiagnoCure Epigenomics EUSA Pharma Exact
Sciences Foundation Medicine
5
Report Description
Fujirebio Diagnostics Genomic Health Geron
Immunomedics Morphotek Myriad Genetics
Nodality Northwest Biotherapeutics Ocimum
Biosolutions Oncothyreon OriGene
Polymedco Radient Pharmaceuticals Randox
Laboratories Siemens Healthcare US
Biomarkers Vermillion
6
Report Description
Market Driver Increased Prevalence of Cancer
For a full, detailed list, view our
report Market Challenge Regulatory and
Reimbursement Issues For a full, detailed list,
view our report Market Trend Growing
Popularity of Companion Diagnostics For a full,
detailed list, view our report Key Questions
Answered in this Report What will the market
size be in 2019 and what will the growth rate
be? What are the key market trends? What is
driving this market? What are the challenges to
market growth? Who are the key vendors in this
market space? What are the market opportunities
and threats faced by the key vendors? What are
the strengths and weaknesses of the key vendors?
7
Table Of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06.
Incidence and Prevalence 08. Biomarkers Used in
Cancer Diagnosis 09. FDA Approval Process for
Protein-Based Cancer Biomarkers 10. Geographical
Segmentation 11. Buying Criteria 12. Market
Growth Drivers 13. Drivers and their Impact 14.
Market Challenges 15. Impact of Drivers and
Challenges 16. Market Trends 17. Trends and their
Impact Get Complete TOC At http//www.bigmarketr
esearch.com/global-cancer-biomarkers-2015-2019-mar
ket
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-cancer-bio
markers-2015-2019-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (855) 711-1555E-MAIL
help_at_bigmarketresearch.com
About PowerShow.com